Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where J. Robert Merritt is active.

Publication


Featured researches published by J. Robert Merritt.


Bioorganic & Medicinal Chemistry Letters | 2008

Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonists.

Younong Yu; Michael P. Dwyer; Jianping Chao; Cynthia J. Aki; Jianhua Chao; Biju Purakkattle; Diane Rindgen; Richard W. Bond; Rosemary Mayer-Ezel; James Jakway; Hongchen Qiu; R. William Hipkin; James Fossetta; Waldemar Gonsiorek; Hong Bian; Xuedong Fan; Carol Terminelli; Jay S. Fine; Daniel Lundell; J. Robert Merritt; Zhenmin He; Gaifa Lai; Minglang Wu; Arthur G. Taveras

Comprehensive SAR studies were undertaken in the 3,4-diaminocyclobut-3-ene-1,2-dione class of CXCR2/CXCR1 receptor antagonists to explore the role of the heterocycle on chemokine receptor binding affinities, functional activity, as well as oral exposure in rat. The nature of the heterocycle as well as the requisite substitution pattern around the heterocycle was shown to have a dramatic effect on the overall biological profile of this class of compounds. The furyl class, particularly the 4-halo adducts, was found to possess superior binding affinities for both the CXCR2 and CXCR1 receptors, functional activity, as well as oral exposure in rat versus other heterocyclic derivatives.


Bioorganic & Medicinal Chemistry Letters | 2008

Synthesis and structure-activity relationships of new disubstituted phenyl-containing 3,4-diamino-3-cyclobutene-1,2-diones as CXCR2 receptor antagonists.

Gaifa Lai; J. Robert Merritt; Zhenmin He; Daming Feng; Jianhua Chao; Michael Czarniecki; Laura L. Rokosz; Tara M. Stauffer; Diane Rindgen; Arthur G. Taveras

A series of 3,4- and 3,5-disubstituted phenyl-containing cyclobutenedione analogues were synthesized and evaluated as CXCR2 receptor antagonists. Variations in the disubstitution pattern of the phenyl ring afforded new compounds with potent CXCR2 binding affinity in the low nanomolar ranges. Moreover, two potent compounds 19 and 26 exhibited good oral pharmacokinetic profiles.


Archive | 2003

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

Arthur G. Taveras; Cynthia J. Aki; Richard W. Bond; Jianping Chao; Michael P. Dwyer; Johan A. Ferreira; Jianhua Chao; Younong Yu; John J. Baldwin; Bernd Kaiser; Ge Li; J. Robert Merritt; Purakkattle J. Biju; Kingsley H. Nelson; Laura Rokosz; James Jakway; Gaifa Lai; Minglang Wu; Evan A. Hecker; Daniel Lundell; Jay S. Fine


Journal of Medicinal Chemistry | 2006

Discovery of 2-Hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): A Potent, Orally Bioavailable CXCR2/CXCR1 Receptor Antagonist

Michael P. Dwyer; Younong Yu; Jianping Chao; Cynthia J. Aki; Jianhua Chao; Purakkattle J. Biju; Viyyoor M. Girijavallabhan; Diane Rindgen; Richard W. Bond; Rosemary Mayer-Ezel; James Jakway; R. William Hipkin; James Fossetta; Waldemar Gonsiorek; Hong Bian; Xuedong Fan; Carol Terminelli; Jay S. Fine; Daniel Lundell; J. Robert Merritt; Laura L. Rokosz; Bernd Kaiser; Ge Li; Wei Wang; Tara M. Stauffer; Lynne Ozgur; Jack E. Baldwin; Arthur G. Taveras


Bioorganic & Medicinal Chemistry Letters | 2007

C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists.

Jianhua Chao; Arthur G. Taveras; Jianping Chao; Cynthia J. Aki; Michael P. Dwyer; Younong Yu; Biju Purakkattle; Diane Rindgen; James Jakway; William Hipkin; James Fosetta; Xuedong Fan; Daniel Lundell; Jay S. Fine; Michael Minnicozzi; Jonathan E. Phillips; J. Robert Merritt


Bioorganic & Medicinal Chemistry Letters | 2006

Synthesis and structure-activity relationships of 3,4-diaminocyclobut-3-ene-1,2-dione CXCR2 antagonists

J. Robert Merritt; Laura L. Rokosz; Kingsley H. Nelson; Bernd Kaiser; Wei Wang; Tara M. Stauffer; Lynne Ozgur; Adriane Schilling; Ge Li; John J. Baldwin; Arthur G. Taveras; Michael P. Dwyer; Jianping Chao


Archive | 2004

Thiadiazoles AS CXC- and CC- chemokine receptor ligands

Purakkattle J. Biju; Arthur G. Taveras; J. Robert Merritt; John J. Baldwin; Younong Yu; Junying Zheng; Jianhua Chao; Cynthia J. Aki


Archive | 2002

3,4-Di-substituted maleimide compounds as CXC chemokine receptor antagonists

Arthur G. Taveras; Michael P. Dwyer; Johan A. Ferreira; Viyyoor M. Girijavallabhan; Jianping Chao; John J. Baldwin; J. Robert Merritt; Ge Li


Archive | 2003

THIADIAZOLEDIOXIDES AND THIADIAZOLEOXIDES AS CXC- AND CC-CHEMOKINE RECEPTOR LIGANDS

Arthur G. Taveras; Jianhua Chao; Purakkattle J. Biju; Younong Yu; Cynthia J. Aki; J. Robert Merritt; Ge Li; John J. Baldwin; Gaifa Lai; Minglang Wu; Evan A. Hecker


Archive | 2004

Isothiazole dioxides as CXC- and CC-chemokine receptor ligands

Arthur G. Taveras; J. Robert Merritt; John J. Baldwin; Junying Zheng; Purakkattle J. Biju; Younong Yu; Jianhua Chao; Gaifa Lai; Minglang Wu

Collaboration


Dive into the J. Robert Merritt's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge